News Focus
News Focus
icon url

Investor2014

12/11/22 12:33 PM

#391551 RE: tradeherpete #391550

The best way to avoid lecanamab etc. that folks here hate, is that Anavex stays on goal presenting unquestionably great full TLD and an acceptable Surrogate Endpoint biomarker from the prespecified subgroup analysis.

I believe lecanemab is a scam with horrible side effects and Biogen is a disreputable company that uses illegal and improper means to make a profit off of unsuspecting, suffering people.


I guess SAVA, Synaptogenix or any other company's potentially successful and safe AD drug could fulfil that hope too.